Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.
Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Hazzan M.
Noël C, et al. Among authors: hazzan m.
J Am Soc Nephrol. 2009 Jun;20(6):1385-92. doi: 10.1681/ASN.2008101037. Epub 2009 May 21.
J Am Soc Nephrol. 2009.
PMID: 19470677
Free PMC article.
Clinical Trial.